NNC0442-0344 A

N/A

Report date: 2026/04/25 20:00:23
NME

Base Information

Drug NameNNC0442-0344 A
Drug Alias NameNNC0442-0344 AInno8NN7442
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor VIII replacements
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesSweden +[12] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk A/S
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A